Published in Rheumatol Int on September 20, 2006
Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis. Ann Rheum Dis (2007) 0.94
Purinergic signalling in the musculoskeletal system. Purinergic Signal (2013) 0.93
Dipyridamole augments the antiinflammatory response during human endotoxemia. Crit Care (2011) 0.92
Clinical and molecular genetics of the phosphodiesterases (PDEs). Endocr Rev (2013) 0.89
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med (2001) 7.41
Measurement of pain. J Rheumatol (1983) 2.58
Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J (2000) 2.53
Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol (1985) (1994) 2.37
Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol (1985) 1.96
Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J Immunol (1996) 1.75
Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis (1994) 1.73
Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol (2000) 1.54
IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation. J Immunol (1999) 1.51
A(2A) adenosine receptors in human peripheral blood cells. Br J Pharmacol (2000) 1.21
ICSH recommendations for measurement of erythrocyte sedimentation rate. International Council for Standardization in Haematology (Expert Panel on Blood Rheology) J Clin Pathol (1993) 1.20
Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. J Immunol (1997) 1.14
Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation. J Cell Sci (1999) 1.10
Adenosine A2 receptor occupancy regulates stimulated neutrophil function via activation of a serine/threonine protein phosphatase. J Biol Chem (1996) 1.09
The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J Leukoc Biol (2002) 1.07
Fc gamma receptor-mediated functions in neutrophils are modulated by adenosine receptor occupancy. A1 receptors are stimulatory and A2 receptors are inhibitory. J Immunol (1990) 1.07
Immunoregulation of IL-6 secretion by endogenous and exogenous adenosine and by exogenous purinergic agonists in splenic tissue slices. J Neuroimmunol (2002) 0.83
Interleukin 1 receptor antagonist anakinra improves functional status in patients with rheumatoid arthritis. J Rheumatol (2003) 0.81
The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target. J R Coll Physicians Lond (1997) 0.80
Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov (2002) 2.61
An expanding range of targets for kynurenine metabolites of tryptophan. Trends Pharmacol Sci (2012) 1.29
Hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells: The effects of glutamate and protection by purines. Bone (2006) 1.21
Restored plasticity in a mouse model of neurofibromatosis type 1 via inhibition of hyperactive ERK and CREB. Eur J Neurosci (2007) 1.10
Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition. Infect Immun (2005) 1.09
Tryptophan metabolites and brain disorders. Clin Chem Lab Med (2003) 1.05
The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders. Br J Pharmacol (2013) 1.04
Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis. Brain (2009) 1.02
Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol (2007) 1.00
Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection. FEBS J (2012) 1.00
Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment. Clin Exp Pharmacol Physiol (2006) 0.98
Electrochemical and in vitro evaluation of the redox-properties of kynurenine species. Biochem Biophys Res Commun (2003) 0.96
Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D: -aspartate receptors in hippocampal slices. Exp Brain Res (2004) 0.94
Responses of differentiated MC3T3-E1 osteoblast-like cells to reactive oxygen species. Eur J Pharmacol (2008) 0.94
Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Adv Exp Med Biol (2003) 0.94
A role for RhoB in synaptic plasticity and the regulation of neuronal morphology. J Neurosci (2010) 0.93
New advances in the rehabilitation of CNS diseases applying rTMS. Expert Rev Neurother (2007) 0.91
On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio. Int J Tryptophan Res (2010) 0.88
Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring. Mol Brain (2012) 0.88
Involvement of kynurenines in Huntington's disease and stroke-induced brain damage. J Neural Transm (Vienna) (2011) 0.88
Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling. Clin Exp Pharmacol Physiol (2008) 0.86
Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment. Adv Exp Med Biol (2003) 0.85
Preconditioning with 4-aminopyridine protects cerebellar granule neurons against excitotoxicity. Brain Res (2009) 0.84
Adenosine receptor ligands protect against a combination of apoptotic and necrotic cell death in cerebellar granule neurons. Exp Brain Res (2007) 0.84
Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease. J Neurochem (2009) 0.84
Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery. J Neurochem (2011) 0.84
Purine, kynurenine, neopterin and lipid peroxidation levels in inflammatory bowel disease. J Biomed Sci (2002) 0.84
5-Hydroxyanthranilic acid, a tryptophan metabolite, generates oxidative stress and neuronal death via p38 activation in cultured cerebellar granule neurones. Neurotox Res (2009) 0.83
Prenatal inhibition of the tryptophan-kynurenine pathway alters synaptic plasticity and protein expression in the rat hippocampus. Brain Res (2013) 0.82
Hydrogen peroxide mediates damage by xanthine and xanthine oxidase in cerebellar granule neuronal cultures. Neurosci Lett (2007) 0.82
Cell death in rat cerebellar granule neurons induced by hydrogen peroxide in vitro: mechanisms and protection by adenosine receptor ligands. Brain Res (2006) 0.82
NMDA-induced preconditioning attenuates synaptic plasticity in the rat hippocampus. Brain Res (2006) 0.81
Glutamate-induced depression of EPSP-spike coupling in rat hippocampal CA1 neurons and modulation by adenosine receptors. Eur J Neurosci (2010) 0.81
Prolonged exposures of cerebellar granule neurons to S-nitroso-N-acetylpenicillamine (SNAP) induce neuronal damage independently of peroxynitrite. Brain Res (2008) 0.80
Altered apoptotic responses in neurons lacking RhoB GTPase. Eur J Neurosci (2011) 0.79
Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring. Eur J Neurosci (2014) 0.78
Gardening with Huntington's disease clients--creating a programme of winter activities. Disabil Rehabil (2010) 0.78
Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons. Brain Res (2008) 0.78
Memory impairment in rats by hippocampal administration of the serine protease subtilisin. Behav Brain Res (2010) 0.77
Preconditioning with NMDA protects against toxicity of 3-nitropropionic acid or glutamate in cultured cerebellar granule neurons. Neurosci Lett (2008) 0.77
AMPA receptor activation reduces epileptiform activity in the rat neocortex. Brain Res (2007) 0.77
Group S8A serine proteases, including a novel enzyme cadeprin, induce long-lasting, metabotropic glutamate receptor-dependent synaptic depression in rat hippocampal slices. Eur J Neurosci (2007) 0.76
Interactions between adenosine and metabotropic glutamate receptors in the rat hippocampal slice. Br J Pharmacol (2003) 0.76
Protection by the flavonoids quercetin and luteolin against peroxide- or menadione-induced oxidative stress in MC3T3-E1 osteoblast cells. Nat Prod Res (2014) 0.76
Xanthine oxidase-induced neuronal death via the oxidation of NADH: prevention by micromolar EDTA. Brain Res (2009) 0.76
A novel dihydro-pyrazolo(3,4d)(1,2,4)triazolo(1,5a)pyrimidin-4-one (AJ23) is an antagonist at adenosine A(1) receptors and enhances consolidation of step-down avoidance. Behav Brain Res (2012) 0.76
Adenosine preconditions against ouabain but not against glutamate on CA1-evoked potentials in rat hippocampal slices. Eur J Neurosci (2008) 0.76
Effects of AMPA and clomethiazole on spreading depression cycles in the rat neocortex in vivo. Eur J Pharmacol (2010) 0.76
LTP-induced depression of response to hypoxia in hippocampus: effects of adenosine receptor activation. Neuroreport (2003) 0.75
Neuroprotective role of learning in dementia: a biological explanation. J Alzheimers Dis (2003) 0.75
Molecular changes associated with hippocampal long-lasting depression induced by the serine protease subtilisin-A. Eur J Neurosci (2011) 0.75
Neuropeptide-containing cells in the cortex and striatum of mice with cerebral malaria. Adv Exp Med Biol (2003) 0.75
Blockade of presynaptic adenosine A1 receptor responses by nitric oxide and superoxide in rat hippocampus. Eur J Neurosci (2004) 0.75
Barium, glibenclamide and CGS21680 prevent adenosine A1 receptor changes of ES coupling and spike threshold. Neurosignals (2005) 0.75
The mechanism of inhibition by xanthine of adenosine A1-receptor responses in rat hippocampus. Neurosci Lett (2004) 0.75
PEGs in chronic neurological disorders. Clin Med (2002) 0.75
Differential effects of remacemide and desglycinyl-remacemide on epileptiform burst firing in the rat hippocampal slice. Neurosci Lett (2002) 0.75
Prenatal activation of maternal TLR3 receptors by viral-mimetic poly(I:C) modifies GluN2B expression in embryos and sonic hedgehog in offspring in the absence of kynurenine pathway activation. Immunopharmacol Immunotoxicol (2013) 0.75
Effects of ethylenediamine in rodent models of seizure, motor coordination and anxiety. Brain Res (2012) 0.75
Corrigendum: Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature (2017) 0.75
Long-term potentiation and adenosine sensitivity are unchanged in the AS/AGU protein kinase Cgamma-deficient rat. Neurosci Lett (2002) 0.75